These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6069927)

  • 21. [Serum complement and C'1, C'2, C'3 and C'4 components in rheumatoid arthritis and collagen diseases].
    Pietruska Z
    Pol Tyg Lek; 1972 Dec; 27(51):2010-3. PubMed ID: 4653713
    [No Abstract]   [Full Text] [Related]  

  • 22. Enharncement of the hemolytic activity of the second component of human complement by oxidation.
    Polley MJ; Müller-Eberhard HJ
    J Exp Med; 1967 Dec; 126(6):1013-25. PubMed ID: 4964564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inactivation of complement and its components by plasmin.
    PILLEMER L; RATNOFF OD; BLUM L; LEPOW IH
    J Exp Med; 1953 Apr; 97(4):573-89. PubMed ID: 13052820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Irregular behavior of complement in coeliac disease (author's transl)].
    Blanco A; Alonso M; Solís P; Calvo C; Catoira A; Sánchez Villares E
    An Esp Pediatr; 1981 Nov; 15(5):449-54. PubMed ID: 7332146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of the complement system with native and chemically modified endotoxins.
    Gewurz H; Mergenhagen SE; Nowotny A; Phillips JK
    J Bacteriol; 1968 Feb; 95(2):397-405. PubMed ID: 4170751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Free radical mechanisms of radiation modification of DNA sugar fragment].
    Sharpatyĭ VA
    Radiats Biol Radioecol; 1997; 37(4):508-11. PubMed ID: 9599604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMPLEMENT AND HEMOLYTIC ANTIBODY: CHANGES IN THEIR ACTIVITY INDUCED BY MERCAPTOETHANOL.
    FRANK MM; BORSOS T; RAPP HJ
    Science; 1965 Feb; 147(3659):742-3. PubMed ID: 14242020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.
    Klemperer MR; Donaldson VH; Rosen FS
    J Clin Invest; 1968 Mar; 47(3):604-11. PubMed ID: 4170149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on immune hemolysis: preparation of a stable and highly reactive complex of sensitized erythrocytes and the first component of complement (EAC'1): inactivation of cell-fixed C'1 by some complement reagents.
    KLEIN PG
    J Exp Med; 1960 Jan; 111(1):77-91. PubMed ID: 13848490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The conversion of C'IS to C'1 esterase by plasmin and trypsin.
    Ratnoff OD; Naff GB
    J Exp Med; 1967 Feb; 125(2):337-58. PubMed ID: 4225264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromatographic resolution of the first component of human complement into three activities.
    LEPOW IH; NAFF GB; TODD EW; PENSKY J; HINZ CF
    J Exp Med; 1963 Jun; 117(6):983-1008. PubMed ID: 13929797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
    Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
    J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.
    Pickering RJ; Wolfson MR; Good RA; Gewurz H
    Proc Natl Acad Sci U S A; 1969 Feb; 62(2):521-7. PubMed ID: 4978744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. 3. Isolation of a gammag normal antibody and characterization of other serum factors causing P32 loss.
    Spitznagel JK
    J Bacteriol; 1966 Jan; 91(1):401-8. PubMed ID: 4159313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.
    RATNOFF OD; LEPOW IH
    J Exp Med; 1963 Nov; 118(5):681-98. PubMed ID: 14087615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaphylatoxin release from the third component of human complement by hydroxylamine.
    Budzko DB; Müller-Eberhard H
    Science; 1969 Aug; 165(3892):506-7. PubMed ID: 5815704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaphylatoxin formation by purified human C'1 esterase.
    Dias da Silva W; Lepow IH
    J Immunol; 1965 Dec; 95(6):1080-9. PubMed ID: 4158798
    [No Abstract]   [Full Text] [Related]  

  • 40. The third component of the guinea pig complement system. II. Kinetic study of the reaction of EAC'4,2a with guinea pig C'3. Enzymatic nature of C'3 comsumption, multiphasic character of fixation, and hemolytic titration of C'3.
    Shin HS; Mayer MM
    Biochemistry; 1968 Aug; 7(8):2997-3002. PubMed ID: 5666766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.